Factors Affecting the Clearance and Biodistribution of Polymeric Nanoparticles
Top Cited Papers
Open Access
- 1 August 2008
- journal article
- review article
- Published by American Chemical Society (ACS) in Molecular Pharmaceutics
- Vol. 5 (4) , 505-515
- https://doi.org/10.1021/mp800051m
Abstract
Nanoparticle (NP) drug delivery systems (5−250 nm) have the potential to improve current disease therapies because of their ability to overcome multiple biological barriers and releasing a therapeutic load in the optimal dosage range. Rapid clearance of circulating nanoparticles during systemic delivery is a critical issue for these systems and has made it necessary to understand the factors affecting particle biodistribution and blood circulation half-life. In this review, we discuss the factors which can influence nanoparticle blood residence time and organ specific accumulation. These factors include interactions with biological barriers and tunable nanoparticle parameters, such as composition, size, core properties, surface modifications (pegylation and surface charge), and finally, targeting ligand functionalization. All these factors have been shown to substantially affect the biodistribution and blood circulation half-life of circulating nanoparticles by reducing the level of nonspecific uptake, delaying opsonization, and increasing the extent of tissue specific accumulation.Keywords
This publication has 106 references indexed in Scilit:
- Precise engineering of targeted nanoparticles by using self-assembled biointegrated block copolymersProceedings of the National Academy of Sciences, 2008
- Impact of tumor-specific targeting on the biodistribution and efficacy of siRNA nanoparticles measured by multimodality in vivo imagingProceedings of the National Academy of Sciences, 2007
- Sheddable Coatings for Long-Circulating NanoparticlesPharmaceutical Research, 2007
- Administration in non-human primates of escalating intravenous doses of targeted nanoparticles containing ribonucleotide reductase subunit M2 siRNAProceedings of the National Academy of Sciences, 2007
- PEG‐PLA Block Copolymer as Potential Drug Carrier: Preparation and CharacterizationMacromolecular Bioscience, 2006
- Formulation of functionalized PLGA–PEG nanoparticles for in vivo targeted drug deliveryPublished by Elsevier ,2006
- Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivoProceedings of the National Academy of Sciences, 2006
- Clinical translation of angiogenesis inhibitorsNature Reviews Cancer, 2002
- Rolling properties of rGPIbα-conjugated phospholipid vesicles with different membrane flexibilities on vWf surface under flow conditionsBiochemical and Biophysical Research Communications, 2002
- Tumor Angiogenesis: Therapeutic ImplicationsNew England Journal of Medicine, 1971